-Graham Casey Researcher Activity Profile

Research Author Detailed Information 

Graham Casey Publication Rate By Year

Graham Casey has published 5 paper(s) in 2006, 12 paper(s) in 2007, 2 paper(s) in 2008, for a total of 19 research publications in total.

Graham G Casey Author Information

LAST NAME: casey

FIRST NAME: graham

INITIALS: G

AFFILIATION:

Papers

Graham Casey's Publication Record

1. Role of IKK and oscillatory NFkappaB kinetics in MMP-9 gene expression and chemoresistance to 5-fluorouracil in RKO colorectal cancer cells. Year Published: 2007
Department of Cancer Biology, Cleveland Clinic, Cleveland, Ohio 44195, and School of Biomedical Sciences, Kent State University, USA.
2. Osteopontin knockdown suppresses tumorigenicity of human metastatic breast carcinoma, MDA-MB-435. Year Published: 2006
University of South Alabama-Mitchell Cancer Institute, Mobile, AL 36688-0002, USA.
3. Nonsteroidal antiinflammatory drugs and decreased risk of advanced prostate cancer: modification by lymphotoxin alpha. Year Published: 2006
Department of Epidemiology and Biostatistics and Center for Human Genetics, University of California, San Francisco, San Francisco, CA 94143, USA.
4. Loss of breast cancer metastasis suppressor 1 protein expression predicts reduced disease-free survival in subsets of breast cancer patients. Year Published: 2006
Department of Clinical and Anatomic Pathology, General Surgery-Breast Center, Lerner Research Institute, The Cleveland Clinic, Cleveland, Ohio 44195, USA.
5. Vitamin D receptor genotypes/haplotypes and prostate cancer risk. Year Published: 2006
Department of Cancer Biology, Lerner Research Institute, Cleveland Clinic, Ohio, USA.
6. Ascending the learning curve--MSI testing experience of a six-laboratory consortium. Year Published: 2006
Department of Medical Genetics, Mayo Clinic, Rochester, MN 55905, USA. nlindor@mayo.edu
7. Breast cancer metastasis suppressor 1 (BRMS1) inhibits osteopontin transcription by abrogating NF-kappaB activation. Year Published: 2007
Mitchell Cancer Institute, University of South Alabama, Mobile, Alabama, USA. rsamant@usouthal.edu
8. Association of testis derived transcript gene variants and prostate cancer risk. Year Published: 2007
Department of Epidemiology and Biostatistics, and Institute for Human Genetics, University of California, San Francisco, San Francisco, California 94143-0794, USA.
9. Toll-like receptor 4 genetic variation and advanced prostate cancer risk. Year Published: 2007
Department of Epidemiology and Biostatistics and Center of Human Genetics, University of California at San Francisco, 94143-0794, USA.
10. Trans-fatty acid intake and increased risk of advanced prostate cancer: modification by RNASEL R462Q variant. Year Published: 2007
Department of Epidemiology and Biostatistics and Institute for Human Genetics, University of California, San Francisco, CA 94143-0794, USA.
11. MIC1 and IL1RN genetic variation and advanced prostate cancer risk. Year Published: 2007
Department of Epidemiology and Biostatistics, University of California, San Francisco, CA 94143-0794, USA.
12. Podocalyxin increases the aggressive phenotype of breast and prostate cancer cells in vitro through its interaction with ezrin. Year Published: 2007
Department of Cancer Biology, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio 44195, USA.
13. ADAMTSL3/punctin-2, a gene frequently mutated in colorectal tumors, is widely expressed in normal and malignant epithelial cells, vascular endothelial cells and other cell types, and its mRNA is reduced in colon cancer. Year Published: 2007
Department of Biomedical Engineering, Cleveland Clinic Foundation, Cleveland, OH 44195, USA.
14. Variants on 9p24 and 8q24 are associated with risk of colorectal cancer: results from the Colon Cancer Family Registry. Year Published: 2007
Department of Preventive Medicine, University of Southern California, 1441 Eastlake Avenue, NOR4411A, Los Angeles, CA 90089-9175, USA. poynter@usc.edu
15. MIC1 and IL1RN genetic variation and advanced prostate cancer risk. Year Published: 2007
Department of Epidemiology and Biostatistics, University of California, San Francisco, CA 94143-0794, USA.
16. MIC1 and IL1RN genetic variation and advanced prostate cancer risk. Year Published: 2007
Department of Epidemiology and Biostatistics, University of California, San Francisco, CA 94143-0794, USA.
17. Variants on 9p24 and 8q24 are associated with risk of colorectal cancer: results from the Colon Cancer Family Registry. Year Published: 2007
Department of Preventive Medicine, University of Southern California, 1441 Eastlake Avenue, NOR4411A, Los Angeles, CA 90089-9175, USA. poynter@usc.edu
18. Association between Phosphatidylinositol 3-Kinase Regulatory Subunit p85{alpha} Met326Ile Genetic Polymorphism and Colon Cancer Risk. Year Published: 2008
Authors' Affiliations: Departments of Family Medicine-Research Division, Epidemiology, and Biostatistics, Case Western Reserve University/University Hospitals of Cleveland.
19. A common 8q24 variant and the risk of colon cancer: a population-based case-control study. Year Published: 2008
Department of Family Medicine-Research Division, Case Western Reserve University, 11001 Cedar Avenue, Suite 306, Cleveland, OH 44106-7136. lxl62@cwru.edu.